Pros and Cons of Ampio Pharmaceuticals Inc. in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Ampio Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ampio Pharmaceuticals Inc. | - | - | - | - | - | - | - |
| Protara Therapeutics Inc. | -2.060% | -17.667% | -10.991% | 53.416% | 10.762% | 54.375% | -64.965% |
| India Globalization Capital | -2.500% | 12.150% | 0.840% | -5.512% | 0.840% | -26.108% | -83.179% |
| Gensight Biologics SA | -5.650% | -5.732% | -2.645% | -68.513% | -31.834% | -97.385% | -99.119% |
Comments
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for AMPE provided by MarketBeat